nifedipine has been researched along with Alveolitis, Fibrosing in 8 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Long-term therapy with aerosolized iloprost (long-acting PGI(2) analog) resulted in unequivocal clinical improvement from a state of immobilization and severe resting dyspnea in a patient with decompensated right heart failure." | 9.09 | Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. ( Ghofrani, HA; Grimminger, F; Olschewski, H; Schermuly, R; Seeger, W; Temmesfeld-Wollbruck, B; Walmrath, D, 1999) |
| "The present study was undertaken to evaluate at rest the short- and long-term effects of oral nifedipine (N) in patients with pulmonary hypertension (PH)." | 7.68 | Short- and long-term hemodynamic effects of oral nifedipine in patients with pulmonary hypertension secondary to COPD and lung fibrosis. Deleterious effects in patients with restrictive disease. ( Domenighetti, GM; Saglini, VG, 1992) |
| "To detect whether pulmonary vascular responsiveness is a factor which can aggravate the pulmonary hypertension induced by irreversible pulmonary fibrosis, we examined the acute hemodynamic effects of low-flow oxygen and of nifedipine both at rest and during exercise in 8 patients with idiopathic pulmonary fibrosis (IPF)." | 7.67 | Pulmonary vascular responsiveness at rest and during exercise in idiopathic pulmonary fibrosis: effects of oxygen and nifedipine. ( Galavotti, V; Gunella, G; Papiris, S; Sturani, C, 1986) |
| " Long-term therapy with aerosolized iloprost (long-acting PGI(2) analog) resulted in unequivocal clinical improvement from a state of immobilization and severe resting dyspnea in a patient with decompensated right heart failure." | 5.09 | Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. ( Ghofrani, HA; Grimminger, F; Olschewski, H; Schermuly, R; Seeger, W; Temmesfeld-Wollbruck, B; Walmrath, D, 1999) |
| "The present study was undertaken to evaluate at rest the short- and long-term effects of oral nifedipine (N) in patients with pulmonary hypertension (PH)." | 3.68 | Short- and long-term hemodynamic effects of oral nifedipine in patients with pulmonary hypertension secondary to COPD and lung fibrosis. Deleterious effects in patients with restrictive disease. ( Domenighetti, GM; Saglini, VG, 1992) |
| "To detect whether pulmonary vascular responsiveness is a factor which can aggravate the pulmonary hypertension induced by irreversible pulmonary fibrosis, we examined the acute hemodynamic effects of low-flow oxygen and of nifedipine both at rest and during exercise in 8 patients with idiopathic pulmonary fibrosis (IPF)." | 3.67 | Pulmonary vascular responsiveness at rest and during exercise in idiopathic pulmonary fibrosis: effects of oxygen and nifedipine. ( Galavotti, V; Gunella, G; Papiris, S; Sturani, C, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mukherjee, S | 1 |
| Ayaub, EA | 1 |
| Murphy, J | 1 |
| Lu, C | 1 |
| Kolb, M | 1 |
| Ask, K | 1 |
| Janssen, LJ | 1 |
| Bergemann, A | 1 |
| Tikly, M | 1 |
| Olschewski, H | 1 |
| Ghofrani, HA | 1 |
| Walmrath, D | 1 |
| Schermuly, R | 1 |
| Temmesfeld-Wollbruck, B | 1 |
| Grimminger, F | 1 |
| Seeger, W | 1 |
| Domenighetti, GM | 1 |
| Saglini, VG | 1 |
| Grisanti, M | 1 |
| Vicencio, M | 1 |
| Sturani, C | 1 |
| Papiris, S | 1 |
| Galavotti, V | 1 |
| Gunella, G | 1 |
| Ohar, J | 1 |
| Polatty, C | 1 |
| Robichaud, A | 1 |
| Fowler, A | 1 |
| Vetrovec, G | 1 |
| Glauser, F | 1 |
| Domenighetti, G | 1 |
1 trial available for nifedipine and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Topics: Administration, Inhalation; Adult; Aged; Atrial Function, Right; Calcium Channel Blockers; Drug Ther | 1999 |
7 other studies available for nifedipine and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Disruption of Calcium Signaling in Fibroblasts and Attenuation of Bleomycin-Induced Fibrosis by Nifedipine.
Topics: Animals; Bleomycin; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Chan | 2015 |
Cystic lung disease in systemic sclerosis: a case report with high resolution computed tomography findings.
Topics: Adult; Antirheumatic Agents; Cysts; Female; Humans; Lung Diseases; Nifedipine; Penicillamine; Pulmon | 1996 |
Short- and long-term hemodynamic effects of oral nifedipine in patients with pulmonary hypertension secondary to COPD and lung fibrosis. Deleterious effects in patients with restrictive disease.
Topics: Aged; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Middl | 1992 |
[Pulmonary involvement in progressive systemic sclerosis].
Topics: Humans; Hypertension, Pulmonary; Lung Diseases; Nifedipine; Penicillamine; Pulmonary Fibrosis; Scler | 1986 |
Pulmonary vascular responsiveness at rest and during exercise in idiopathic pulmonary fibrosis: effects of oxygen and nifedipine.
Topics: Adult; Blood Pressure; Exercise Test; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Ni | 1986 |
The role of vasodilators in patients with progressive systemic sclerosis. Interstitial lung disease and pulmonary hypertension.
Topics: Humans; Hydralazine; Hypertension, Pulmonary; Lung Diseases; Nifedipine; Pulmonary Fibrosis; Sarcoid | 1985 |
[Variable hemodynamic response to nifedipine in pulmonary hypertension secondary to chronic obstructive bronchopathy and pulmonary fibrosis].
Topics: Blood Pressure; Cardiac Output; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Lung Diseases | 1985 |